Mark R. Ziebell
2013
In 2013, Mark R. Ziebell earned a total compensation of $610.3K as Vice President, General Counsel and Corporate Secretary at Peregrine Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $111,501 |
|---|---|
| Option Awards | $217,800 |
| Salary | $252,000 |
| Other | $28,954 |
| Total | $610,255 |
Ziebell received $252K in salary, accounting for 41% of the total pay in 2013.
Ziebell also received $111.5K in non-equity incentive plan, $217.8K in option awards and $29K in other compensation.
Rankings
In 2013, Mark R. Ziebell's compensation ranked 8,655th out of 12,286 executives tracked by ExecPay. In other words, Ziebell earned more than 29.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,655 out of 12,286 | 30th |
Division Manufacturing | 3,145 out of 4,612 | 32nd |
Major group Chemicals And Allied Products | 998 out of 1,466 | 32nd |
Industry group Drugs | 758 out of 1,160 | 35th |
Industry Pharmaceutical Preparations | 599 out of 890 | 33rd |
Source: SEC filing on August 28, 2014.
Ziebell's colleagues
We found five more compensation records of executives who worked with Mark R. Ziebell at Peregrine Pharmaceuticals in 2013.
2013
Steven King
Peregrine Pharmaceuticals
Chief Executive Officer
2013
Paul Lytle
Peregrine Pharmaceuticals
Chief Financial Officer
2013
Jeffrey Masten
Peregrine Pharmaceuticals
Former Vice President, Quality
2013
Shelley Fussey
Peregrine Pharmaceuticals
Vice President, Intellectual Property
2013
Joseph Shan
Peregrine Pharmaceuticals
Vice President, Clinical & Regulatory Affairs
News
Peregrine Pharmaceuticals CEO Nicholas Green's 2023 pay rises 5% to $6.5M
August 28, 2023
Peregrine Pharmaceuticals CEO Nicholas Green's 2022 pay jumps 117% to $6.2M
August 29, 2022
Peregrine Pharmaceuticals CEO Nicholas Green receives $2.8M in 2021
August 27, 2021
Peregrine Pharmaceuticals General Counsel Mark Ziebell's 2020 pay jumps 124% to $1.1M
August 27, 2020
Peregrine Pharmaceuticals CEO Roger Lias' 2019 pay jumps 25% to $880K
August 21, 2019
Peregrine Pharmaceuticals CEO Roger Lias receives $704K in 2018
August 17, 2018